Provided by Tiger Trade Technology Pte. Ltd.

FUSEN PHARM

0.800
+0.0405.26%
Volume:67.00K
Turnover:50.65K
Market Cap:591.20M
PE:-2.83
High:0.800
Open:0.760
Low:0.740
Close:0.760
52wk High:1.750
52wk Low:0.235
Shares:739.00M
HK Float Shares:739.00M
Volume Ratio:2.37
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.283
ROE:-40.49%
ROA:-2.47%
PB:1.54
PE(LYR):-2.83
PS:2.21

Loading ...

Fusen Pharmaceutical (1652) Announces Further Details on Disposal of Henan Fusen Energy Conservation Unit

Bulletin Express
·
Oct 27

What Fusen Pharmaceutical Company Limited's (HKG:1652) 159% Share Price Gain Is Not Telling You

Simply Wall St.
·
Oct 05

FUSEN PHARM (01652): Yu Haoming Appointed as Independent Non-Executive Director

Stock News
·
Sep 30

Fusen Pharmaceutical Announces Board and Audit Committee Changes: Mr. Sze Wing Chun Resigns, Mr. Yu Ho Ming and Mr. Lee Kwok Tung Louis Appointed

Reuters
·
Sep 30

Fusen Pharmaceutical Unit Offloads Entire Stake in Henan Fusen Intelligent

MT Newswires Live
·
Sep 22

FUSEN PHARM (01652) Subsidiary to Sell All Equity in Henan Fusen Smart Energy-Saving Technology for RMB 73 Million

Stock News
·
Sep 22

Fusen Pharmaceutical - Unit Announces Disposal of Henan Fusen Intelligent Energy Conservation Technology Equity for RMB73.0 Million

THOMSON REUTERS
·
Sep 22

Intraday Surge Exceeds 400%! FUSEN PHARM Announces Major Positive Development

Deep News
·
Sep 16

BRIEF-Fusen Pharmaceutical Gets Approval For Metformin Empagliflozin Tablets

Reuters
·
Sep 16

FUSEN PHARM (01652): "Metformin Empagliflozin Tablets (I)" Approved for Market Launch

Stock News
·
Sep 15

Fusen Pharmaceutical Receives Regulatory Approval for "Metformin Empagliflozin Tablets (I)" for Type 2 Diabetes Treatment

Reuters
·
Sep 15

Fusen Pharmaceutical Co Ltd - Approval From Nmpa

THOMSON REUTERS
·
Sep 15

FUSEN PHARM (01652) Reports Interim Results with Shareholder Loss of RMB 23.136 Million, Narrowing 37.37% Year-on-Year

Stock News
·
Aug 29

Fusen Pharmaceutical H1 Capex RMB 7.3 Million

THOMSON REUTERS
·
Aug 29

Fusen Pharmaceutical H1 Gross Margin 38.6%

THOMSON REUTERS
·
Aug 29